相关产品推荐更多 >

FGF14抗体FGF14兔多抗抗体FHF-4 antibody抗体FGF14 Antibody抗体
¥440
ARL2BP抗体ARL2BP一抗抗体RP66 antibody抗体ARL2BP Antibody抗体
¥880
ZCCHC13抗体ZCCHC13兔多抗抗体Zinc finger CCHC domain-containing protein 13 antibody抗体ZCCHC13 Antibody, FITC conjugated抗体
¥880
AURKB抗体AURKB一抗抗体STK5 antibody抗体Phospho-AURKB (T232) Antibody抗体
¥880
ZHX1-C8orf76抗体ZHX1-C8orf76兔多抗抗体ZHX1-C8orf76 readthrough transcript protein antibody抗体ZHX1-C8orf76 Antibody, FITC conjugated抗体
¥880
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Synthesized peptide derived from Human Mitogen-activated protein kinase kinase kinase 7 protein (179-194aa)
- 亚型:
IgG
- 形态:
Liquid
- 保存条件:
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性:
Polyclonal
- 标记物:
Non-conjugated
- 适应物种:
Human
- 保质期:
6个月
- 抗原来源:
Homo sapiens (Human)
- 目录编号:
O43318
- 级别:
优
- 库存:
200
- 供应商:
武汉华美生物工程有限公司
- 宿主:
Rabbit
- 应用范围:
ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:100-1:500
- 浓度:
>95%,Antigen Affinity Purified
- 靶点:
MAP3K7
- 抗体英文名:
MAP3K7 (Ab-187) Antibody
- 抗体名:
Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1);MAP3K7;TAK1
- 规格:
100μl/50μl/20μl
| 规格: | 100μl | 产品价格: | ¥1320.0 |
|---|---|---|---|
| 规格: | 50μl | 产品价格: | ¥880.0 |
| 规格: | 20μl | 产品价格: | ¥440.0 |
保存缓冲液
Preservative: 0.03% Proclin 300Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
功能
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR). Ceramides are also able to activate MAP3K7/TAK1. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs, c-jun N-terminal kinases (JNKs) and I-kappa-B kinase complex (IKK). Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1), while nuclear factor-kappa B is activated by IKK. MAP3K7 activates also IKBKB and MAPK8/JNK1 in response to TRAF6 signaling and mediates BMP2-induced apoptosis. In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B. Promotes TRIM5 capsid-specific restriction activity.风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验dongreyuan 有的抗体名称上面写着Ab-33,比如,β-catenin(Ab-33)antibody,请问,Ab-33是什么意思? bettyzyj 这个抗体是非磷酸化的抗体non-phospho-antibody ,33 代表的是基因位点 dongreyuan 谢谢了 yhwangcams bettyzyj wrote
Cell Metab:西京医院王琳教授团队报道非酒精性脂肪肝炎新靶点
,TRIM16 可抑制 JNK-p38 通路的激活。 图片来源:Thermo Fisher TRIM16 促进磷酸化的 TAK1 的蛋白酶体降解TRIM16 又是如何抑制 JNK-p38 通路激活的呢?为了确定 TRIM16 抑制 JNK-p38 通路的具体靶点,作者在肝细胞中过表达 TRIM16,并进行了免疫沉淀 - 质谱(IP-MS)分析。通过整合 IP-MS 和定量泛素组学的结果,作者筛选到 3 个 MAPK 通路成员,其中 TAK1(也叫 MAP3K7)已被证实在 NASH 进展过程中发挥关键
AB0系统的抗体是检验主管技师考试的内容,医学教育网搜集整理相关内容供大家参考。 天然抗体与免疫性抗体:天然抗体是在没有可觉察的抗原刺激下而产生的抗体,以IgM为主,又称完全抗体或盐水抗体;也可能是由一种无觉察的免疫刺激产生而得。免疫性抗体:有IgM、IgG、IgA,但主要是IgG.抗A和抗B可以是IgM与IgG,甚至是IgM、IgG、IgA的混合物,但主要是IgM,而0型血清中以IgG为主。
技术资料暂无技术资料 索取技术资料






